Asia Pacific Mid-Size Pharmaceutical Market to 2028 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Asia Pacific Mid-Size Pharmaceutical Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Asia Pacific Mid-Size Pharmaceutical Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Rising Investment towards Improvement of Pharmaceutical Manufacturing Capabilities to boost the mid-size pharmaceutical market

5.2 Market Opportunities

5.2.1 Active participation of market players in product innovation and developments fuel the growth of the mid-size pharmaceutical market

5.3 Future Trends

5.3.1 Adoption of Tech Transfer and Outsourcing Trends providing a significant growth opportunity for the mid-size pharmaceutical market

5.4 Impact of Drivers and Restraints

6. Asia Pacific Mid-Size Pharmaceutical Market Regional Analysis

6.1 Asia Pacific Mid-Size Pharmaceutical Market Overview

6.2 Asia Pacific Mid-Size Pharmaceutical Market Revenue 2020-2028 (US$ Million)

6.3 Asia Pacific Mid-Size Pharmaceutical Market Forecast Analysis

7. Asia Pacific Mid-Size Pharmaceutical Market Analysis – by Type

7.1 Prescription

7.1.1 Overview
7.1.2 Prescription: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Over-the-Counter

7.2.1 Overview
7.2.2 Over-the-Counter: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Mid-Size Pharmaceutical Market Analysis – by Drug Development Type

8.1 In-House

8.1.1 Overview
8.1.2 In-House: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Outsource

8.2.1 Overview
8.2.2 Outsource: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Mid-Size Pharmaceutical Market Analysis – by Formulation

9.1 Tablets and Capsules

9.1.1 Overview
9.1.2 Outsource: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Injectables

9.2.1 Overview
9.2.2 Outsource: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Sprays

9.3.1 Overview
9.3.2 Outsource: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Other Formulations

9.4.1 Overview
9.4.2 Outsource: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Mid-Size Pharmaceutical Market – Asia-Pacific Analysis

10.1 Asia-Pacific

10.1.1 Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Key Country, 2023 and 2028 (%)
10.1.1.1 Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast Analysis – by Country
10.1.1.1 China: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 China: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Type
10.1.1.1.2 China: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Drug Development Type
10.1.1.1.3 China: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Formulation

10.1.1.2 India: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 India: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Type
10.1.1.2.2 India: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Drug Development Type
10.1.1.2.3 India: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Formulation

10.1.1.3 Japan: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Japan: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Type
10.1.1.3.2 Japan: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Drug Development Type
10.1.1.3.3 Japan: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Formulation

10.1.1.4 Australia: Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Australia: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Type
10.1.1.4.2 Australia: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Drug Development Type
10.1.1.4.3 Australia: Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Formulation

10.1.1.5 Rest of Asia-Pacific : Asia Pacific Mid-Size Pharmaceutical Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Type
10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Drug Development Type
10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Mid-Size Pharmaceutical Market Breakdown, by Formulation

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Asia Pacific Mid-Size Pharmaceutical Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Alexion Pharmaceuticals, Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Bausch Health Companies Inc.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Daiichi Sankyo Company Limited

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Eisai Co., Ltd.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Endo Pharmaceuticals Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Mallinckrodt

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Regeneron Pharmaceuticals, Inc

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Sun Pharmaceutical Industries Ltd

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights